Peter Åsman

1.6k total citations
39 papers, 1.2k citations indexed

About

Peter Åsman is a scholar working on Ophthalmology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Åsman has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Ophthalmology, 16 papers in Pathology and Forensic Medicine and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Åsman's work include Glaucoma and retinal disorders (16 papers), Ophthalmology and Eye Disorders (16 papers) and Retinal Imaging and Analysis (9 papers). Peter Åsman is often cited by papers focused on Glaucoma and retinal disorders (16 papers), Ophthalmology and Eye Disorders (16 papers) and Retinal Imaging and Analysis (9 papers). Peter Åsman collaborates with scholars based in Sweden, United States and United Kingdom. Peter Åsman's co-authors include Anders Heijl, Bengt Hallengren, Mikael Lantz, Tereza Planck, Mikael Lantz, Hemang Parikh, Georg Lindgren, Boel Bengtsson, Anna Lindgren and Frank Träisk and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Ophthalmology and European Journal of Endocrinology.

In The Last Decade

Peter Åsman

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Åsman Sweden 18 712 462 373 307 148 39 1.2k
Leonardo Provetti Cunha Brazil 16 526 0.7× 300 0.6× 94 0.3× 109 0.4× 47 0.3× 54 701
Yoichi Inoue Japan 12 1.1k 1.6× 637 1.4× 459 1.2× 222 0.7× 15 0.1× 21 1.4k
Lissa Padnick‐Silver United States 16 510 0.7× 345 0.7× 97 0.3× 47 0.2× 60 0.4× 37 808
K Frost-Larsen Denmark 15 424 0.6× 361 0.8× 46 0.1× 273 0.9× 147 1.0× 30 999
Divakar Gupta United States 15 523 0.7× 339 0.7× 61 0.2× 22 0.1× 134 0.9× 41 905
H. Dunbar Hoskins United States 23 1.1k 1.5× 632 1.4× 173 0.5× 20 0.1× 100 0.7× 45 1.3k
J. J. Wang Australia 13 393 0.6× 323 0.7× 63 0.2× 70 0.2× 23 0.2× 23 661
Ida Dielemans Netherlands 8 2.0k 2.8× 1.5k 3.2× 131 0.4× 44 0.1× 34 0.2× 8 2.2k
Norman S. Levy United States 15 476 0.7× 229 0.5× 138 0.4× 19 0.1× 102 0.7× 33 777
Zofia Mariak Poland 17 764 1.1× 453 1.0× 90 0.2× 13 0.0× 94 0.6× 129 1.0k

Countries citing papers authored by Peter Åsman

Since Specialization
Citations

This map shows the geographic impact of Peter Åsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Åsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Åsman more than expected).

Fields of papers citing papers by Peter Åsman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Åsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Åsman. The network helps show where Peter Åsman may publish in the future.

Co-authorship network of co-authors of Peter Åsman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Åsman. A scholar is included among the top collaborators of Peter Åsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Åsman. Peter Åsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Planck, Tereza, Vijayachitra Modhukur, Anna Sundlöv, et al.. (2021). Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres. Endocrine. 75(3). 856–864. 4 indexed citations
3.
Lindgren, Ola, Anna Sundlöv, Jan Tennvall, et al.. (2019). The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves’ Disease. European Thyroid Journal. 8(2). 64–69. 9 indexed citations
4.
Lantz, Mikael, Jan Calissendorff, Frank Träisk, et al.. (2016). Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations. European Thyroid Journal. 5(1). 50–56. 9 indexed citations
5.
Hallengren, Bengt, Tereza Planck, Peter Åsman, & Mikael Lantz. (2015). Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report. European Thyroid Journal. 4(3). 197–200. 7 indexed citations
6.
Planck, Tereza, Hemang Parikh, Kristoffer Ström, et al.. (2014). Smoking Induces Overexpression of Immediate Early Genes in Active Graves' Ophthalmopathy. Thyroid. 24(10). 1524–1532. 30 indexed citations
7.
Åsman, Peter, et al.. (2012). Cataract surgeons outperform medical students in Eyesi virtual reality cataract surgery: evidence for construct validity. Acta Ophthalmologica. 91(5). 469–474. 47 indexed citations
8.
Åsman, Peter, et al.. (2010). Virtual reality cataract surgery training: learning curves and concurrent validity. Acta Ophthalmologica. 90(5). 412–417. 62 indexed citations
9.
Abraham‐Nordling, Mirna, Göran Wallin, Frank Träisk, et al.. (2010). Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine. European Journal of Endocrinology. 163(4). 651–657. 26 indexed citations
10.
Åsman, Peter & Christina Lindén. (2010). Internet‐based assessment of medical students’ ophthalmoscopy skills. Acta Ophthalmologica. 88(8). 854–857. 18 indexed citations
11.
Träisk, Frank, Leif Tallstedt, Mirna Abraham‐Nordling, et al.. (2009). Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131. The Journal of Clinical Endocrinology & Metabolism. 94(10). 3700–3707. 172 indexed citations
12.
Lantz, Mikael, Hemang Parikh, Martin Ridderstråle, et al.. (2005). Overexpression of Immediate Early Genes in Active Graves’ Ophthalmopathy. The Journal of Clinical Endocrinology & Metabolism. 90(8). 4784–4791. 52 indexed citations
13.
Åsman, Peter. (2003). Ophthalmological evaluation in thyroid‐associated ophthalmopathy. Acta Ophthalmologica Scandinavica. 81(5). 437–448. 33 indexed citations
14.
Åsman, Peter, et al.. (2002). Accidental mydriasis from exposure to Angel's trumpet (Datura suaveolens). Acta Ophthalmologica Scandinavica. 80(3). 332–335. 22 indexed citations
15.
Gundersen, Kjell Gunnar & Peter Åsman. (2000). Comparison of ranked segment analysis (RSA) and cup to disc ratio in computer‐assisted optic disc evaluation. Acta Ophthalmologica Scandinavica. 78(2). 137–141. 6 indexed citations
16.
Olsson, Jonny, Peter Åsman, & Anders Heijl. (1997). A perimetric learner's index. Acta Ophthalmologica Scandinavica. 75(6). 665–668. 8 indexed citations
17.
Åsman, Peter & Jonny Olsson. (1995). Physiology of cumulative defect curves; consequences in glaucoma perimetry. Acta Ophthalmologica Scandinavica. 73(3). 197–201. 7 indexed citations
18.
Åsman, Peter. (1992). Computer-assisted interpretation of visual fields in glaucoma.. PubMed. 1–47. 5 indexed citations
19.
Åsman, Peter & Anders Heijl. (1992). Weighting according to location in computer‐assisted glaucoma visual field analysis. Acta Ophthalmologica. 70(5). 671–678. 4 indexed citations
20.
Åsman, Peter, et al.. (1988). Evaluation of Adaptive Spatial Enhancement in Suprathreshold Visual Field Screening. Ophthalmology. 95(12). 1656–1662. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026